TYK2 Kinase Inhibitoren

European patent · EP2634185 · In force

Register entry

Publication number
EP2634185
Application number
EP13157419
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 1, 2013
Published
Sep 4, 2013
Granted
Jan 13, 2016
Protection ends at the latest
Feb 28, 2033
Next annual fee due
Mar 31, 2027
IPC classes
C07D 413/12 (2006.01)
C07D 263/48 (2006.01)
A61P 29/00 (2006.01)
A61P 17/06 (2006.01)
A61P 37/06 (2006.01)
A61K 31/421 (2006.01)
A61K 31/422 (2006.01)
Priority
US 201261605952 P 02.03.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Mar 10, 2016

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 10.03.2016

  6. Jan 13, 2016

    Granted

    Published in Swissreg on 13.01.2016

Parties

Holder

Sareum Limited

Unit 2A, Langford Arch London Road, Pampisford Cambridge, CB22 3FX, GB

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

Reader, John, Charles

Cambridge, Cambridgeshire CB22 3FX, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.